This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources March 15, 2011
ASCLS eNewsBytes
March 15, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources


Breast cancer guideline updated at 2011 NCCN
Medscape Medical News    Share   Share on FacebookTwitterShare on LinkedinE-mail article
New systemic treatment options for women with metastatic disease highlight the recently updated breast cancer guideline from the National Comprehensive Cancer Network (NCCN), which was presented here at the NCCN 16th Annual Conference. However, the headlining element of the guideline might be described as controversial; the breast cancer panel made recommendations on issues such as forgoing axillary lymph node dissection (despite positive nodes) and the use of bevacizumab in advanced disease. More



Genetics is 'top of the pops' in science research
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Genetics is still the hottest area of scientific research, a decade on from the mapping of the human genome, despite slow progress in translating discoveries into new medical treatments. A Thomson Reuters Science Watch survey found seven of the top 13 researchers in 2010 worked in genetics. More

Britain considers allowing 3-parent IVF technique
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Britain is considering whether to approve a fertility treatment designed to prevent some incurable inherited diseases under which babies would be conceived from three biological parents. More

Polymer cloak gives blood cells anonymity, possibly allowing universal transfusions
Popular Science    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Anyone who has ever donated blood has learned his or her blood type, such as AB, O negative, etc., which will be matched to a recipient with the same blood type. If blood types do not match, a recipient's immune system could reject the transfusion, a potentially fatal proposition. But a new method masks the type of donated red blood cells, possibly eliminating the need to test types and making it easier to give and receive blood. More

Qualiris by Stago

Qualiris by Stago is a Web-based External Quality Assessment program used to provide enhanced confidence for your hemostasis testing. Qualiris provides peer-group, result comparisons from a global to a local level. Stago's dedicated experts are available 24/7 to help interpret your results. For more information on Quadfsliris visit www.stago-us.com.


Scientists grow viable urethras from boys' cells
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have used patients' own cells to grow urinary tubes in the lab and have successfully used them to replace damaged tissue in five young boys, showing the potential power of cell-based therapies. Urine flow tests and tube diameter measurements show the tissue-engineered urethras are still working after six years, said Dr. Anthony Atala, director of the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center in North Carolina. More

Study: Adults with HIV at increased risk of bone fractures
HealthDay News via Bloomberg Businessweek    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Adults infected with HIV — particularly adults between 25 and 54 — are at increased risk for bone fractures compared to the general population, a new study has found. It's known that low bone mineral density is common in people with HIV, but there is little data on bone fracture rates in this group of patients. More

'T-reg' cells keep us healthy
ScienceAlert    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists from the Walter and Eliza Hall Institute have identified the key immune cell population responsible for regulating the body's immune response. The finding could have wide-ranging repercussions for the treatment of autoimmune diseases, organ transplantation and cancer, and change how the efficacy of newly developed drugs is measured. More



Biomarker panel identifies asthma, COPD
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A combination of four blood proteins may serve as biomarkers to help clinicians distinguish patients with asthma from those with chronic obstructive pulmonary disease (COPD), Australian researchers report. These proteins have "the potential to be a valuable tool in the clinical diagnosis of respiratory disease," they write in an article published in the American Journal of Respiratory and Critical Care Medicine. More

Rescue NET for lupus patients
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Lupus is a disease where the immune system attacks healthy cells of the body. This leads to progressive damage of different tissues and organs. The classical characteristic of the disease is the so-called butterfly rash in the face. Many Lupus patients eventually die of kidney failure. Scientists at the Max Planck Institute for Infection Biology in Berlin together with medical scientists from the University of Erlangen succeeded in elucidating basic principles of the disease. This opens up new perspectives for methods that might enable early diagnosis and treatment of Lupus patients with a high risk at kidney failure. More



Serum test could define need for SLN biopsy in melanoma
Internal Medicine News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The development of a serum glycoprotein microarray has led to the discovery of four proteins for which antibodies significantly predict nodal metastases in patients with melanoma. If validated, the data could form the basis of a blood test to select patients for sentinel lymph node biopsy, Dr. Michael Sabel said during a symposium sponsored by the Society of Surgical Oncology. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Contact us at 1-800-379-0957.
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes.
More
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Colby Horton, Vice President of Publishing
469.420.2601

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor
469.420.2641.

Recent Issues

  • March 8, 2011
  • March 1, 2011
  • Dedicated - Bio-Rad
  • Feb. 22, 2011
  • Feb. 15, 2011
  •  RSS Feed
    Most popular articles